Clinical and cost effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for the treatment of pulmonary arterial hypertension in adults: a systematic review and economic evaluation

Yen-Fu Chen, Susan Jowett, Pelham Barton, Kinga Malottki, Christopher Hyde, S Gibbs, J Pepke-Zaba, Anne Fry-Smith, J Roberts, David Moore

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-320
JournalHealth Technology Assessment
Issue number49
Publication statusPublished - 1 Jan 2010

Cite this